Both in Pharmaceuticals
Ultragenyx Pharmaceutical vs Kailera Therapeutics
Over the past year RARE returned +8.3% and KLRA returned −16.7%; their daily moves had a correlation of 0.09.
RARE +8.3% KLRA −16.7%Growth of $1, one year, split-adjusted
| Metric | RARE | KLRA |
|---|---|---|
| Price | $15.48 | $11.61 |
| Market cap | $1.53B | $1.51B |
| Today | +1.24% | +16.10% |
| 1 month | +7.5% | — |
| 6 months | −33.6% | — |
| Year to date | −32.7% | — |
| 1 year | −49.8% | — |
| Revenue growth (YoY) | +28.1% | — |
| Gross margin | 84.1% | — |
| Net margin | −43.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.1× | — |
| Net cash | $292.0M | $916.7M |
| Dividend yield | — | — |
| Volatility (60d) | 127.7% | — |
| Short % of float | 21.8% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).